Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit K Jain

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Lung Cancer (Auckland, N.Z.)|October 28, 2017
Spotlight on brigatinib and its potential in the treatment of patients with metastatic ALK-positive non-small cell lung cancer who are resistant or intolerant to crizotinibRohit K Jain, Hongbin Chen
Expert Review of Anticancer Therapy|June 18, 2020
Neoadjuvant therapy for muscle-invasive bladder cancerRohit K Jain, Guru Sonpavde
Urologic Oncology|September 10, 2017
Second-line systemic therapy in metastatic renal-cell carcinoma: A reviewRohit K Jain, Shipra Gandhi, Saby George
Pathology Oncology Research : POR|April 9, 2010
Conjunctival squamous cell carcinoma due to ocular prostheses: a case report and review of literatureRohit K Jain, Rutika Mehta, Sunil Badve
Clinical Breast Cancer|March 23, 2011
Personalized medicine: the road aheadRutika Mehta, Rohit K Jain, Sunil Badve
European Urology|August 8, 2021
Re: Andrea Necchi, Laura Marandino, Daniele Raggi, et al. Is it Time to Consider Eliminating Surgery from the Treatment of Locally Advanced Bladder Cancer? Eur Urol 2021;79:713-6Roger Li, Rohit K Jain, Wade J Sexton
Annals of Translational Medicine|April 30, 2019
Important caveats of KEYNOTE-045: relevance of these findings in the current and future therapeutic paradigmJulio Slongo, Rohit K Jain, Philippe E Spiess
BJU International|August 23, 2019
Non-invasive diagnosis and monitoring of urothelial bladder cancer: are we there yet?Rohit K Jain, Petros Grivas, Sumanta K Pal
Cells|August 14, 2019
Clinical Development of PARP Inhibitors in Treating Metastatic Castration-Resistant Prostate CancerJacob J Adashek, Rohit K Jain, Jingsong Zhang
Cancer Management and Research|September 28, 2020
Emerging Treatment Options for the Treatment of Metastatic Urothelial Cancer: Therapeutic Potential of Enfortumab VedotinRohit K Jain, William Paul Skelton, Jingsong Zhang
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Lung Cancer (Auckland, N.Z.)|October 28, 2017
Spotlight on brigatinib and its potential in the treatment of patients with metastatic ALK-positive non-small cell lung cancer who are resistant or intolerant to crizotinibRohit K Jain, Hongbin Chen
Expert Review of Anticancer Therapy|June 18, 2020
Neoadjuvant therapy for muscle-invasive bladder cancerRohit K Jain, Guru Sonpavde
Urologic Oncology|September 10, 2017
Second-line systemic therapy in metastatic renal-cell carcinoma: A reviewRohit K Jain, Shipra Gandhi, Saby George
Pathology Oncology Research : POR|April 9, 2010
Conjunctival squamous cell carcinoma due to ocular prostheses: a case report and review of literatureRohit K Jain, Rutika Mehta, Sunil Badve
Clinical Breast Cancer|March 23, 2011
Personalized medicine: the road aheadRutika Mehta, Rohit K Jain, Sunil Badve
European Urology|August 8, 2021
Re: Andrea Necchi, Laura Marandino, Daniele Raggi, et al. Is it Time to Consider Eliminating Surgery from the Treatment of Locally Advanced Bladder Cancer? Eur Urol 2021;79:713-6Roger Li, Rohit K Jain, Wade J Sexton
Annals of Translational Medicine|April 30, 2019
Important caveats of KEYNOTE-045: relevance of these findings in the current and future therapeutic paradigmJulio Slongo, Rohit K Jain, Philippe E Spiess
BJU International|August 23, 2019
Non-invasive diagnosis and monitoring of urothelial bladder cancer: are we there yet?Rohit K Jain, Petros Grivas, Sumanta K Pal
Cells|August 14, 2019
Clinical Development of PARP Inhibitors in Treating Metastatic Castration-Resistant Prostate CancerJacob J Adashek, Rohit K Jain, Jingsong Zhang
Cancer Management and Research|September 28, 2020
Emerging Treatment Options for the Treatment of Metastatic Urothelial Cancer: Therapeutic Potential of Enfortumab VedotinRohit K Jain, William Paul Skelton, Jingsong Zhang
Pageof 6